In conclusion, our study suggested that purine metabolism strongly correlates with oxaliplatin resistance in CRC and that a Wnt/β‐catenin/IMPDH2 positive feedback circuit confers oxaliplatin resistance (Fig. 7F). Here, IMPDH2 is linked to colorectal carcinoma.